
    
      The purpose of this clinical trial is to further evaluate the safety and effectiveness of
      progesterone in the clinical application of major cerebral congestion diseases. The Second
      Affiliated Hospital of Zhejiang University is the unit in charge of clinical research, and
      six units participate in the multicenter randomized, double-blind, placebo-controlled
      clinical trial.
    
  